Glenmark launches malaria treatment drug in UK

Thu Feb 7, 2013 8:19pm IST

Related Topics

Stocks

   

REUTERS - Drugmaker Glenmark Pharmaceuticals Ltd (GLEN.NS) said on Thursday its European unit had launched a generic version of GlaxoSmithKline's (GSK.L) Malarone malaria treatment medicine, its first generic product in Britain.

Glenmark launched the drug after the revocation of Glaxo's patent on Malarone by the High Court in Britain, the Indian company said in a statement, adding the medicine had sales of $28 million in the year ended September.

(Reporting by Sumeet Chatterjee in MUMBAI; editing by Jane Baird)

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

  • Most Popular
  • Most Shared

Fuelling Change

REUTERS SHOWCASE

NSEL Fraud

NSEL Fraud

Govt orders Financial Tech to absorb NSEL, liabilities  Full Article 

Quarterly Result

Quarterly Result

HDFC Bank net profit up 20 percent, lags estimates.  Full Article 

JLR China

JLR China

JLR sees 20 percent growth in China sales this year - exec  Full Article 

China Economy

China Economy

China's growth slowest since global crisis, annual target at risk  Full Article 

Coal Reforms

Coal Reforms

Factbox - India pushes ahead with coal reforms  Full Article 

Apple Result

Apple Result

Apple's iPhone sales beat Street but iPad volumes slide  Full Article 

Airport Accident

Airport Accident

Total CEO de Margerie killed in Moscow business jet accident  Full Article 

Nadella's Paycheck

Nadella's Paycheck

New Microsoft CEO Nadella's pay tops $80 mln with big stock awards.  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage